Skip to main content
. 2023 Mar 15;14:1067973. doi: 10.3389/fphar.2023.1067973

TABLE 3.

Rate of resistance according to the most common multiresistant strains of bacteria at HSAL Doboj in 2021.

J01 antimicrobial agent R Acinetobacter baumanii I R Klebsiella spp. I R Pseudomonas spp. I R Staphylococcus aureus I R Coagulase-negative I Staphylococcus spp. R Proteus I R E. coli I
Ampicillin 93.8 6.2 35.3 40.5 79.1 16.7 82.0 12.6 62.0 37.0
Amoxicillin 91.0 8.9 36.0 40.3 79.1 16.7 84.0 15.0 59.1 40.0
Amox/clav 81.3 6.3 15.6 35.5 62.5 12.5 76.0 7.00 54.0 23.3
Pip/taz 24.2 14.1 15.3 38.6 2.3 0.00 36.3 4.6
Cefalexin 79.3 6.3 11.5 7.8 58.3 12.6 66.0 7.0 16.3 23.4
Cefuroxime 70.2 6.3 67.0 10.0 22.3 9.3
Ceftazidime 55.2 8.9 26.9 43.3 29.0 22.0 12.7 9.4
Ceftriaxone 38.9 12 26.2 28.1 9.2 9.3
Cefotaxime 67.1 2.2 59.4 3.9 20.3 4.7
Cefepime 34.8 17.2 20.4 38.9 9.9 7.0
Imipenem 49.5 10.5 2.2 8.8 24.7 33.8 0.4 0.0
Meropenem 66.0 23.6 8.8 13.9 25.7 11.0 9.2 20.9 1.3 3.5
Erythromycin 33.3
N 8.0
Clindamycin 25.0 0.0 75.0 0.0
Tetracycline 9.6 27.9 25.0 41.7
Gentamicin 76.3 15.0 27.8 40.3 16.0 26.0 25.5 40.0 11.8 45.0
Amikacin 70.1 15.9 13.8 23.6 14.8 4.90 6.1 2.5 13.8 20.4 35.0 1.8 28.2
Ciprofloxacin 6.2 6.7 21.7 6.9 22.8 7.9
N 91.3 58.8 47.4 27.2 30.5
TMS 91.9 6.2 53.4 10.3 14.1 15.5 20.9 37.6 6.4
Colistin 0.0 0.0

R, resistant; S, sensitive; I, intermediate; Amox/clav, amoxicillin/clavulanic acid; Pip/taz, piperacillin/tazobactam; TMS, trimethoprim/sulfamethoxazole.